SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Inverness Medical Innovation - IMA
IMA 7.260+4.9%10:51 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: Crossy who started this subject1/28/2003 6:49:21 AM
From: Crossy   of 40
 
Inverness Medical Innovations, Inc.
AMEX: IMA
Sector : Healthcare
Industry: Biotechnology & Drugs


IMA is engaged in the business of developing and manufacturing products for the women's health market and to a lesser extent, diagnostic products for the infectious disease market. For the 9 months ended 9/02, revenues totaled $142.9M, up from $34.3M. Net loss from cont. ops. before extra. items & acct. change applic. to Common totaled $41M, vs. an income of $573K. Results reflect the acquisition of Unipath, offset by $12.7M in impairment cost. Inverness Medical Innovations, Inc.
51 Sawyer Road, Suite 200
Waltham, MA 02453
Phone: (781 ) 647-3900
Fax:
--------------------------------------------------------------------------------

Sector: Healthcare

Industry: Biotechnology & Drugs

Employees: 1,171 (03/25/2002)

Market Cap (Mil) $ : 236.69

Complete Financials: Sep 2002

Updated: 01/18/2003

Earnings Announcements:
NA



OFFICERS: Ron Zwanziger, Chmn./Pres./CEO, Anthony Bernardo, COO/VP, Duane L. James, VP-Fin./Treas., Paul T. Hempel, Counsel/Secy. TRANSFER AGENT: EquiServe Trust Company. Company incorporated 2001 in DE. Direct inquiries to: Director of Investor Relations.

Key Ratios & Statistics
Price & Volume
Recent Price $ 15.90
52 Week High $ 28.25
52 Week Low $ 7.70
Avg Daily Vol (Mil) 0.05
Beta NA
Share Related Items
Mkt. Cap. (Mil) $ 236.69
Shares Out (Mil) 14.89
Float (Mil) 10.80
Dividend Information
Yield % NA
Annual Dividend 0.00
Payout Ratio (TTM) % 0.00
Financial Strength
Quick Ratio (MRQ) 0.76
Current Ratio (MRQ) 1.30
LT Debt/Equity (MRQ) 0.54
Total Debt/Equity (MRQ) 0.57
Valuation Ratios
Price/Earnings (TTM) NM
Price/Sales (TTM) 0.81
Price/Book (MRQ) 1.46
Price/Cash Flow (TTM) NM
Per Share Data
Earnings (TTM) $ -9.23
Sales (TTM) $ 19.50
Book Value (MRQ) $ 10.88
Cash Flow (TTM) $ -4.57
Cash (MRQ) $ 1.13
Mgmt Effectiveness
Return on Equity (TTM) -68.51
Return on Assets (TTM) -21.47
Return on Investment (TTM) -28.35
Profitability
Gross Margin (TTM) % 44.35
Operating Margin (TTM) % -25.51
Profit Margin (TTM) % -34.43

Mil = Millions MRQ = Most Recent Quarter TTM = Trailing Twelve Months
Asterisks (*) Indicates numbers are derived from Earnings Announcements
Pricing and volume data as of 01/17/2003

GROWTH RATES
1 Year 3 Years 5 Years
Sales % -3.26 -12.86 28.63
EPS % NM NM NM
Dividend % NM NM NM


REVENUE
Quarters 1999 2000 2001 2002
MAR 18,866 13,455 11,484 37,246
JUN 18,842 12,743 11,647 51,710
SEP 19,813 12,519 11,159 53,947
DEC 21,773 12,334 15,095

Totals 79,294 51,051 49,385 142,903
Note: Units in Thousands of U.S. Dollars


EARNINGS PER SHARE
Quarters 1999 2000 2001 2002
MAR 0.000 0.210 0.120 -4.140
JUN 0.000 0.230 0.020 -0.580
SEP 0.000 0.060 -0.040 -0.650
DEC 0.000 0.110 -3.860

Totals 0.000 0.610 -3.760 -5.370
Note: Units in U.S. Dollars
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext